Joshua B. Cohen
Co-Chief Executive Officer at Amylyx Pharmaceuticals. Based in Cambridge, Massachusetts.
- Rank
- 1598th of 14,452
- Companies held
- 1
- Largest holding
- AMLX, 100.0% of total
- Latest SEC filing
- Nov 9, 2026
What the $92.0M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Amylyx Pharmaceuticals AMLX Common Stock | Directly | 3,513,123 | $26.20 | $92.0M | 100.0% | Form 4, Nov 9, 2026 |
Share counts are the amounts Joshua B. Cohen reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 9, 2026 | Sold | AMLX | 38,105 | $29.39 | $1.1M | View |
| Nov 9, 2026 | Sold | AMLX | 61,895 | $30.11 | $1.9M | View |
| Sep 10, 2026 | Sold | AMLX | 919 | $33.15 | $30K | View |
| Sep 10, 2026 | Sold | AMLX | 29,545 | $32.16 | $950K | View |
| Mar 2, 2026 | Sold | AMLX | 29,282 | $14.48 | $424K | View |
| Feb 2, 2026 | Sold | AMLX | 15,500 | $14.68 | $228K | View |
| Jan 16, 2026 | Sold | AMLX | 1,974 | $13.83 | $27K | View |
| Jan 15, 2026 | Sold | AMLX | 136,193 | $13.59 | $1.9M | View |
| Jan 6, 2026 | Sold | AMLX | 7,715 | $11.09 | $86K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 1595 | Daniel S. Shugar Chief Executive Officer, Nextpower. Fremont, CA | $92.3M |
| 1596 | J. Duncan Smith Vice President/Secretary, Sinclair. Cockeysville, MD | $92.2M |
| 1597 | Zhitao He Director, Newegg Commerce. Diamond Bar, CA | $92.1M |
| 1598 | Joshua B. Cohen Co-Chief Executive Officer, Amylyx Pharmaceuticals. Cambridge, MA | $92.0M |
| 1599 | Justin B. Klee Co-Chief Executive Officer, Amylyx Pharmaceuticals. Cambridge, MA | $92.0M |
| 1600 | Daniel O'Day Chairman & CEO, Gilead Sciences. Foster City, CA | $91.9M |
| 1601 | Rehan Jaffer Director, Six Flags Entertainment. New York, NY | $91.8M |
Other Amylyx Pharmaceuticals insiders
All AMLX insiders- Justin B. Klee$92.0MCo-Chief Executive Officer. #1599 overall
- George M. Milne Jr.$20.5MDirector. #4876 overall
- James M. Frates$10.1MChief Financial Officer. #8734 overall
- Camille L. Bedrosian$7.3MChief Medical Officer. #9589 overall
- Margaret Olinger$7.2MChief Commercial Officer. #11150 overall
- Patrick D. Yeramian$5.4MChief Medical Officer. #13745 overall
Questions
How much stock does Joshua B. Cohen own?
Joshua B. Cohen holds $92,043,823 in listed stock based on SEC filings and current prices, mostly Amylyx Pharmaceuticals (AMLX). That ranks 1598th on the Stock Rich List.
Is this Joshua B. Cohen's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Joshua B. Cohen last buy or sell stock?
The most recent open-market trade on file is a sale of 38,105 AMLX shares on Nov 9, 2026 at $29.39.